Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03044093

Enrollment

200

Registered

2017-02-06

Start date

2017-01-31

Completion date

2019-01-31

Last updated

2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Second Trimester Abortion

Brief summary

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial

Interventions

DRUGMifepristone

The group that will get in addition to Misoprostol also Mifepristone

DRUGPlacebo

The group that will only get Misoprostol

DRUGMisoprostol

Both groups will get think drug

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy * no allergy known to these drugs * second trimester abortion

Exclusion criteria

* hematology diseases * clotting factor deficiency

Design outcomes

Primary

Measure	Time frame	Description
Reduction in Hospital Stay Duration	Up to 24 months	number of days of hospital stay

Countries

Israel

Contacts

Primary ContactMEIR NIZRI, MD

972-50-2061521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026